Chengdu Taihe Health Technology Group Inc Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chengdu Taihe Health Technology Group Inc Ltd with three other
companies in this sector in China:
Coland Holdings Limited
sales of 586.59 million Chinese Renmimbi [US$84.72 million]
of which 100%
was Medical Services),
Chongqing Pharscin Pharmaceutical Co LtdChongqing Pharscin Pharmaceutical Co L td
(592.10 million Chinese Renmimbi [US$85.52 million]
of which 82%
was Medicine Industry), and
Lansen Pharmaceutical Holdings Limited
(602.67 million Chinese Renmimbi [US$87.04 million]
of which 76%
was Specialty Pharmaceuticals).
During the year ended December of 2017, sales at
Chengdu Taihe Health Technology Group Inc Ltd were 590.95 million Chinese Renmimbi (US$85.35 million).
increase of 2.8%
versus 2016, when the company's sales were 575.04 million Chinese Renmimbi.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Chengdu Taihe Health Technology Group Inc Ltd had sales
of 578.25 million Chinese Renmimbi.
Sales of Medicine Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
12.8% in 2017, from
449.65 million Chinese Renmimbi to 507.01 million Chinese Renmimbi.
Not all segments of Chengdu Taihe Health Technology Group Inc Ltd experienced an increase in sales in 2017:
sales of Others fell 87.2% to 1.12 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Chengdu Taihe Health Technology Group Inc Ltd also experienced decreases in sales in
Steel Structure Design and Manufacturing (down 29.1% to 82.82 million Chinese Renmimbi)